Hot selling vitamin k1 oil vitamin k1 oil
USD $1 - $900 /Kilogram
Min.Order:1 Kilogram
Hebei Xinqidian Biotechnology Co., Ltd.
1.Introduction
Vitamin K is a fat-soluble vitamin needed to produce blood-clotting factors, such as prothrombin, that prevent unchecked bleeding or hemorrhaging throughout the body. It also helps strengthen the body’s bones and capillaries.
Vitamin K comes in three forms: phylloquinone, menaquinone, and menadione. Phylloquinone, or K1, is found in green leafy vegetables, and helps bones absorb and store calcium. One recent study showed that increased amounts of vitamin K in the diet might lower the risk of hip fracture; over time, a shortage of vitamin K could lead to osteoporosis. Menaquinone, or K2, is manufactured in the body by naturally occurring intestinal bacteria. People that regularly take antibiotics or have a medical condition that upsets the balance of bacteria in the intestine are at risk of developing a vitamin K deficiency. Menadione, or vitamin K3, is an artificial form of vitamin K, which is water-soluble and more easily absorbed by people who have problems with fat absorption.
2.TOYOND Vitamin K series:
1. Vitamin K1
2. Vitamin K2 (MK-4 & MK-7 & MK-9)
3. Vitamin K3 (MSB & MNB & MPB)
4. Vitamin K4
3.Function:
1.This product is the necessary substance for liver to combine the prothrombinase II, VII, IX, X. The shortage of vitamin k1 can caused disorder or abnormal synthesis of prothrombinase. Clinically, there may be a tendency to bleed to extent the coagulating time.
2.Vitamin k1 also has analgesic and relieving-spasm roles. It has obvious effects to cure the angina of visceral unstriped muscle, angina caused by duct cramps and intestinal cramps.
3.In recent years, reports said that High-dose vitamin K1 can promote liver cell viability, enhanced monocyte-macrophage phagocytosis, so it has a certain effect to chronic hepatitis.
4.As a pharmaceutical, it is widely used in clinical bleeding caused by a lack of vitamin k1, Such as bleeding caused by obstructive jaundice, biliary fistula, chronic diarrhea; low prothrombin hyperlipidemia caused by Coumarins and sodium salicylate; Hemorrhage of newborn and shortage of vitamin k1 caused by long-term use of broad-spectrum antibiotics. As a Nutrition Enhancer, it is widely used to produce multi-vitamin foodstuff and livestock fodder.
4.Applications:
Pharmaceutical preparations:
For the manufacture of solid products with vitamin K1 as the sole active ingredient, as well as multivitamin and mineral preparations, e.g. tablets, sugar-coated tablets, instant drink granules, effervescent tablets, hard gelatin capsules.
Food products:
For the fortification of baby food and children's food, dietetic foods, instant drink powders, dried milk, and forr vitamin mixtures for the food industry. Dry vitamin K1 5% can also be used in multivitamin fruit juices and confectionery, e.g. multivitamin sweets. Very suitable for the manufacture of hypoallergenic foods, as the product contains no protein.
Specification of Vitamin K2 MK-7
Product Name: Menatetrenone 2-Methyl-3-all-trans-famesyl digeranyl-1,4-naphthoquinone; MK-7 | CAS No.: 27670-94-6 |
Mol. Weight: 649.0 | Mol. Formula: C46H64O2 |
Items | Specification | Results |
Purity (HPLC, Menaquinone-7) | ≥1.0% (>10000 ug/G) | 1.03% |
Pharm.excipient (CaHPO4) | ≥95.0% | 95.8% |
Identification | Yellow brown precipitate | Yellow brown precipitate |
pH | 7.0~8.0 | 7.3 |
Loss on drying | ≤10.0% | 5.2% |
Residue on ignition | ≤0.1% | <0.1% |
Reducing sugar | ≤0.2% | <0.2% |
Fatty acid | Negative | Negative |
Starch | Negative | Negative |
Heavy metals | ≤10ppm | <10ppm |
Arsenic | ≤2ppm | Complies |
Pesticides residue | Negative | Negative |
Total aerobic count (CFU/g) | ≤1000 | Complies |
Yeasts & Molds (CFU/g) | ≤100 | Complies |
Salmonella SP. | Negative | Negative |
E. coli | Negative | Negative |
Appearance | Pale yellow or white crystalline powder | Pale yellow or white crystalline powder |
Conclusion: Complies with the requirement of In-house standard. Storage: Store at 0~8°C temperature. Protect from moisture. Exp.: Sep. 2014 |